218 related articles for article (PubMed ID: 9827256)
21. The influence of dosing schedules and cerebrospinal fluid bactericidal activity on the therapy of bacterial meningitis.
Scheld WM; Tauber MG; Zak O; Sande MA
J Antimicrob Chemother; 1985 Jan; 15 Suppl A():303-12. PubMed ID: 3980333
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics and pharmacodynamics of cephalosporins in cerebrospinal fluid.
Lutsar I; Friedland IR
Clin Pharmacokinet; 2000 Nov; 39(5):335-43. PubMed ID: 11108433
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of antibacterial agents in the CSF of children and adolescents.
Sullins AK; Abdel-Rahman SM
Paediatr Drugs; 2013 Apr; 15(2):93-117. PubMed ID: 23529866
[TBL] [Abstract][Full Text] [Related]
24. Does dexamethasone affect ceftriaxone [corrected] penetration into cerebrospinal fluid in adult bacterial meningitis.
Buke AC; Cavusoglu C; Karasulu E; Karakartal G
Int J Antimicrob Agents; 2003 May; 21(5):452-6. PubMed ID: 12727079
[TBL] [Abstract][Full Text] [Related]
25. Penetration of Vancomycin into the Cerebrospinal Fluid: A Systematic Review.
Beach JE; Perrott J; Turgeon RD; Ensom MHH
Clin Pharmacokinet; 2017 Dec; 56(12):1479-1490. PubMed ID: 28528396
[TBL] [Abstract][Full Text] [Related]
26. Population Pharmacokinetics and Dosing Regimen Optimization of Meropenem in Cerebrospinal Fluid and Plasma in Patients with Meningitis after Neurosurgery.
Lu C; Zhang Y; Chen M; Zhong P; Chen Y; Yu J; Wu X; Wu J; Zhang J
Antimicrob Agents Chemother; 2016 Nov; 60(11):6619-6625. PubMed ID: 27572392
[TBL] [Abstract][Full Text] [Related]
27. Cerebrospinal fluid penetration and pharmacokinetics of vancomycin administered by continuous infusion to mechanically ventilated patients in an intensive care unit.
Albanèse J; Léone M; Bruguerolle B; Ayem ML; Lacarelle B; Martin C
Antimicrob Agents Chemother; 2000 May; 44(5):1356-8. PubMed ID: 10770777
[TBL] [Abstract][Full Text] [Related]
28. Antibiotic prophylaxis in cerebrospinal fluid shunting: reassessment of Cefotiam penetration into human CSF.
Knoop M; Schütze M; Piek J; Drewelow B; Mundkowski R
Zentralbl Neurochir; 2007 Feb; 68(1):14-8. PubMed ID: 17487803
[TBL] [Abstract][Full Text] [Related]
29. Pharmacodynamics and pharmacokinetics of A-80556 using microdialysis in a Streptococcus pneumoniae meningitis model.
Destache CJ; Pakiz CB; Stoysich AM
J Antimicrob Chemother; 1996 Dec; 38(6):977-85. PubMed ID: 9023645
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic drug monitoring of cerebrospinal fluid vancomycin concentration during intraventricular administration.
Popa D; Loewenstein L; Lam SW; Neuner EA; Ahrens CL; Bhimraj A
J Hosp Infect; 2016 Feb; 92(2):199-202. PubMed ID: 26654472
[TBL] [Abstract][Full Text] [Related]
31. Is First-Line Vancomycin Still the Best Option to Treat Staphylococcus Health Care-Associated Meningitis?
Mounier R; Lobo D; Hulin A; Nebbad B; Cook F; Dhonneur G
World Neurosurg; 2017 Mar; 99():812.e1-812.e5. PubMed ID: 28034813
[TBL] [Abstract][Full Text] [Related]
32. Antimicrobial action and pharmacokinetics/pharmacodynamics: the use of AUIC to improve efficacy and avoid resistance.
Schentag JJ
J Chemother; 1999 Dec; 11(6):426-39. PubMed ID: 10678784
[TBL] [Abstract][Full Text] [Related]
33. Assessment of antibiotic efficacy in acute bacterial meningitis.
Beam TR; Allen JC
Clin Pharmacol Ther; 1979 Feb; 25(2):199-203. PubMed ID: 759073
[TBL] [Abstract][Full Text] [Related]
34. Cefotaxime and ceftriaxone cerebrospinal fluid levels during treatment of bacterial meningitis in children.
Goldwater PN
Int J Antimicrob Agents; 2005 Nov; 26(5):408-11. PubMed ID: 16216469
[TBL] [Abstract][Full Text] [Related]
35. Cerebrospinal fluid compartmental pharmacokinetics of amikacin in neonates.
Allegaert K; Scheers I; Adams E; Brajanoski G; Cossey V; Anderson BJ
Antimicrob Agents Chemother; 2008 Jun; 52(6):1934-9. PubMed ID: 18378715
[TBL] [Abstract][Full Text] [Related]
36. [Penetration of antibiotics into the cerebrospinal fluid. Theoretical and practical aspects (author's transl)].
Modai J
Nouv Presse Med; 1980 Dec; 9(47):3615-20. PubMed ID: 6937071
[TBL] [Abstract][Full Text] [Related]
37. The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome. Focus on antibacterial agents.
Hyatt JM; McKinnon PS; Zimmer GS; Schentag JJ
Clin Pharmacokinet; 1995 Feb; 28(2):143-60. PubMed ID: 7736689
[TBL] [Abstract][Full Text] [Related]
38. Exploring the Factors Affecting the Transferability of Vancomycin to Cerebrospinal Fluid in Postoperative Neurosurgical Patients with Bacterial Meningitis.
Ichinose N; Shinoda K; Yoshikawa G; Fukao E; Enoki Y; Taguchi K; Oda T; Tsutsumi K; Matsumoto K
Biol Pharm Bull; 2022; 45(9):1398-1402. PubMed ID: 36047211
[TBL] [Abstract][Full Text] [Related]
39. [Pharmacokinetic criteria of the choice of antibiotic for antibiotic prophylaxis in surgery].
Garraffo R; Pharm D
Ann Fr Anesth Reanim; 1994; 13(5 Suppl):S34-44. PubMed ID: 7778811
[TBL] [Abstract][Full Text] [Related]
40. Correlation of in vitro activity and pharmacokinetic parameters with effect in vivo for antibiotics. Observations from experimental pneumococcus infection.
Frimodt-Møller N
Dan Med Bull; 1988 Oct; 35(5):422-37. PubMed ID: 3066588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
